Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1032 of 6351
-
Heart attack drug shows promise in reducing inflammation
Disease control CompletedVascular and myocardial inflammation are significantly increased in Acute Coronary Syndrome (ACS) patients, are closely correlated to LDL-C levels, and are associated with these adverse consequences in the post-ACS patient population. Serum proprotein convertase subtilisin/kerin …
Phase 2 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Immune cell booster trial offers hope for blood cancer relapse after transplant
Disease control Recruiting nowThis research study is studying cytokine induced memory-like natural killer (CIML NK) cells combined with IL-2 in adult patients (18 years of age or older) with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Myeloproliferative Neoplasms (MPN) who relapse after h…
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
A soothing voice in the ICU: could positive suggestions curb Post-Intensive care anxiety?
Symptom relief CompletedThe Researchers are trying to evaluate efficacy of a psychotherapeutic approach that can be applied to those who are critically ill. The daily approach in the Intensive Care Unit (ICU) is designed to provide patients with psychological support, reassurance, and explanations of wh…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat GI cancers
Disease control CompletedThis is a multicenter, global, Phase 2, open-label, 2-part, first-line study to investigate the safety, tolerability, and anti-tumor activity of ZW25 (zanidatamab) plus standard first-line combination chemotherapy regimens for selected gastrointestinal (GI) cancers. Eligible pati…
Phase 2 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Jun 26, 2026 16:12 UTC
-
Could removing certain immune cells prevent a deadly transplant complication?
Disease control OngoingThis phase II trial studies how well naive T-cell depletion works in preventing chronic graft-versus-host disease in children and young adults with blood cancers undergoing donor stem cell transplant. Sometimes the transplanted white blood cells from a donor attack the body's nor…
Phase 2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Brain oxygen monitoring may boost recovery after severe head trauma
Disease control OngoingBOOST3 is a randomized clinical trial to determine the comparative effectiveness of two strategies for monitoring and treating patients with traumatic brain injury (TBI) in the intensive care unit (ICU). The study will determine the safety and efficacy of a strategy guided by tre…
Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New proton therapy aims to shield memory in kids with brain cancer
Disease control Recruiting nowLow-grade gliomas (LGGs) are the most common brain tumors in children, and a subset of these tumors are treated definitively with focal radiation therapy (RT). These patients often survive for many years after receiving RT and experience late deficits in memory. Verbal recall is …
Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a bone drug make dense breasts less Cancer-Prone?
Prevention OngoingData supporting a role for RANKL signaling in mammographic density and breast cancer development has begun to emerge, but clinical trial data providing definitive evidence that would allow the adoption of RANKL inhibition in primary breast cancer prevention are not yet available.…
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Hope for breast cancer patients: new drug combo may delay recurrence
Disease control OngoingPOLAR is a phase III clinical trial, which will test the safety and efficacy of an investigational combination of drugs to learn whether the combination of drugs works for a specific cancer. Palbociclib (Ibrance®) is the name of the investigational agent, which is assessed togeth…
Phase 3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a Two-Vaccine strategy better shield spleenless patients from pneumonia?
Disease control CompletedThis research is a multi-center French randomized and double blind phase IIb clinical trial evaluating 2 revaccination strategies against pneumococcal infections among splenectomised patients. The main objective is to evaluate at M13 the immunological response of 2 pneumococcal r…
Phase 2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New monthly shot cuts migraine days in half for chronic sufferers?
Disease control CompletedThe purpose of this study was to evaluate the efficacy and safety of erenumab in patients with chronic migraine in Asian population.
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a plasma beam stop colon polyps from coming back?
Prevention CompletedEndoscopic Mucosal Resection (EMR) is the current standard for effective endoscopic resection of such colon adenomas. If resection is possible in one piece (so-called "en bloc" resection) then recurrence rates are low. However, most non-pedunculated polyps \>2 cm are removed in p…
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Prevention
Last updated Sep 10, 2026 00:00 UTC
-
New drug combo shows promise against tough lymphoma
Disease control OngoingThis is a prospective single-arm, multi-center and phase II clinical trial to observe the efficacy and safety of Camrelizumab combined with AVD in the first-line treatment for patients with advanced classical Hodgkin's lymphoma.
Phase 2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
A simple test could spot who will develop stomach cancer
Diagnosis OngoingThis study is carried out to find out if a customized molecular test can identify a subgroup of patients with very-high-risk of developing stomach cancer within patients with intestinal metaplasia (IM). The investigators hypothesise that the incidence of dysplasia and GC cases in…
Sponsor: National University Hospital, Singapore • Aim: Diagnosis
Last updated Aug 09, 2026 00:00 UTC
-
Can a tiny clip fix a leaky heart valve and spare patients from Open-Heart surgery?
Disease control OngoingThis is a postmarket clinical follow up study on the safety and effectiveness of the Edwards PASCAL Transcatheter Valve Repair System and the Edwards PASCAL Precision Transcatheter Valve Repair System in transcatheter mitral valve repair.
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New drug cocktail aims to shrink lymphoma without chemo
Disease control OngoingBackground: The disease follicular lymphoma (FL) develops when the body makes abnormal B-cells. These cells usually build up in the lymph nodes, but can also affect other parts of the body. Researchers want to see if a combination of drugs can attack the cancer cells in people w…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New drug combo may shield kids from transplant complications
Disease control OngoingThis trial will see if extended abatacept administration (combined with a standard regimen of tacrolimus and mycophenolate mofetil) will prevent acute and chronic graft-versus-host disease (GVHD) in children and adolescents receiving unrelated donor (URD) hematopoietic stem cell …
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Heart shield for breast cancer patients: Beta-Blocker may prevent Chemo-Induced damage
Disease control Stopped earlyBreast cancer patients undergoing trastuzumab-based HER2-directed therapy are at risk of heart function decline or heart failure symptoms, but it is unknown if, when, and for how long cardiovascular protective strategies, e.g. with a beta-blocker, could help. This study randomly …
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Genetically modified immune cells take on eight cancer types in early trial
Disease control OngoingThis study will investigate the safety and tolerability of ADP-A2M4CD8 T-cell therapy in subjects who have the appropriate human leukocyte antigen (HLA) and MAGE-A4 tumor antigen. Tumor indications include endometrial, esophageal, esophagogastric junction (EGJ), gastric, head and…
Phase 1 • Sponsor: USWM CT, LLC • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Gene test may spare breast cancer patients from unnecessary radiation
Disease control Recruiting nowThe purpose of this study is to validate whether clinically low-risk, and RecurIndex high-risk N1 patients receiving regional lymph node radiotherapy can further improve clinical outcomes.
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC